Literature DB >> 24488662

The effect of bumetanide treatment on the sensory behaviours of a young girl with Asperger syndrome.

Marine Grandgeorge1, Eric Lemonnier, Céline Degrez, Nelle Jallot.   

Abstract

Sensory behaviours were not considered as core features of autism spectrum disorders until recently. However, they constitute an important part of the observed symptoms that result in social maladjustment and are currently quite difficult to treat. One promising strategy for the treatment of these behaviours is the use of bumetanide, which was previously shown to reduce the severity of autism spectrum disorders. In this study, we proposed to evaluate sensory behaviours using Dunn's Sensory Profile after 18 months of bumetanide treatment in a 10-year-old girl with Asperger syndrome. Reported improvements covered a large range of sensory behaviours, including auditory, vestibular, tactile, multisensory and oral sensory processing. Although our results were limited to a single case report, we believe that our clinical observations warrant clinical trials to test the long-term efficacy of bumetanide to manage the sensory behaviours of people with autism spectrum disorders.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24488662      PMCID: PMC3912375          DOI: 10.1136/bcr-2013-202092

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  38 in total

Review 1.  Interventions to facilitate auditory, visual, and motor integration in autism: a review of the evidence.

Authors:  G Dawson; R Watling
Journal:  J Autism Dev Disord       Date:  2000-10

2.  The clinical global impressions scale: applying a research tool in clinical practice.

Authors:  Joan Busner; Steven D Targum
Journal:  Psychiatry (Edgmont)       Date:  2007-07

Review 3.  Sensory processing in children with autism spectrum disorders and impact on functioning.

Authors:  Michelle A Suarez
Journal:  Pediatr Clin North Am       Date:  2012-02       Impact factor: 3.278

4.  The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.

Authors:  C Lord; S Risi; L Lambrecht; E H Cook; B L Leventhal; P C DiLavore; A Pickles; M Rutter
Journal:  J Autism Dev Disord       Date:  2000-06

5.  A comparison of patterns of sensory processing in children with and without developmental disabilities.

Authors:  Phoebe P P Cheung; Andrew M H Siu
Journal:  Res Dev Disabil       Date:  2009-08-08

6.  The diuretic bumetanide decreases autistic behaviour in five infants treated during 3 months with no side effects.

Authors:  Eric Lemonnier; Yehezkel Ben-Ari
Journal:  Acta Paediatr       Date:  2010-12       Impact factor: 2.299

7.  Severe impairments of social interaction and associated abnormalities in children: epidemiology and classification.

Authors:  L Wing; J Gould
Journal:  J Autism Dev Disord       Date:  1979-03

8.  Sensory responsiveness as a predictor of social severity in children with high functioning autism spectrum disorders.

Authors:  Claudia L Hilton; Jacquelyn D Harper; Rachel Holmes Kueker; Andrea Runzi Lang; Anna M Abbacchi; Alexandre Todorov; Patricia D LaVesser
Journal:  J Autism Dev Disord       Date:  2010-08

9.  Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes.

Authors:  Hsiao-Tuan Chao; Hongmei Chen; Rodney C Samaco; Mingshan Xue; Maria Chahrour; Jong Yoo; Jeffrey L Neul; Shiaoching Gong; Hui-Chen Lu; Nathaniel Heintz; Marc Ekker; John L R Rubenstein; Jeffrey L Noebels; Christian Rosenmund; Huda Y Zoghbi
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

Review 10.  Efficacy and safety of aripiprazole in child and adolescent patients.

Authors:  Eiji Kirino
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-03-25       Impact factor: 4.785

View more
  5 in total

1.  Bumetanide As a Candidate Treatment for Behavioral Problems in Tuberous Sclerosis Complex.

Authors:  Chantal Vlaskamp; Simon-Shlomo Poil; Floor Jansen; Klaus Linkenkaer-Hansen; Sarah Durston; Bob Oranje; Hilgo Bruining
Journal:  Front Neurol       Date:  2017-09-08       Impact factor: 4.003

2.  INTERNEURONOPATHIES AND THEIR ROLE IN EARLY LIFE EPILEPSIES AND NEURODEVELOPMENTAL DISORDERS.

Authors:  Anna-Maria Katsarou; Solomon L Moshé; Aristea S Galanopoulou
Journal:  Epilepsia Open       Date:  2017-06-28

Review 3.  Targeting the WNK-SPAK/OSR1 Pathway and Cation-Chloride Cotransporters for the Therapy of Stroke.

Authors:  Sunday Solomon Josiah; Nur Farah Meor Azlan; Jinwei Zhang
Journal:  Int J Mol Sci       Date:  2021-01-27       Impact factor: 5.923

4.  Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials).

Authors:  Véronique Crutel; Estelle Lambert; Pierre-François Penelaud; Cristina Albarrán Severo; Joaquin Fuentes; Antoine Rosier; Amaia Hervás; Stéphane Marret; Guiomar Oliveira; Mara Parellada; Simon Kyaga; Sylvie Gouttefangeas; Marianne Bertrand; Denis Ravel; Bruno Falissard
Journal:  J Autism Dev Disord       Date:  2021-08

5.  Discovery of a Small Molecule Drug Candidate for Selective NKCC1 Inhibition in Brain Disorders.

Authors:  Annalisa Savardi; Marco Borgogno; Roberto Narducci; Giuseppina La Sala; Jose Antonio Ortega; Maria Summa; Andrea Armirotti; Rosalia Bertorelli; Andrea Contestabile; Marco De Vivo; Laura Cancedda
Journal:  Chem       Date:  2020-08-06       Impact factor: 22.804

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.